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Abstract
Background: Clear cells are observed histopathologically in both benign and malignant neoplasms but their pres-
ence in salivary gland tumors has not been extensively documented. 
Material and Methods: With IRB approval, the archive of the University of Florida College of Dentistry oral 
pathology biopsy service was retrospectively searched from 1994-2014 for all benign and malignant salivary tu-
mors.  Epidemiological data, tumor location and duration, and type of tumor were recorded. A four reviewer panel 
examined the original slides. Reviewers scaled each case as 0 (no clear cells present), 1 (few to focal clear cells), 2 
(less than 50% clear cells), and 3 (greater than 50% clear cells). 
Results: A total of 535 cases were included of which 48% of tumors displayed 0 clear cells (257/535), 31.4% 
(168/535) scored 1, 13.6% (73/535) scored 2, and 7% (37/535) scored 3. Of the 251 (47%) malignant neoplasms, 
64% (160/251) demonstrated 0-1 clear cell change, while 36% (91/251) showed a score of 2-3. For the total 284 
(53%) benign tumors, 93% (265/535) scored 0-1 and 7% (19/535) scored a 2-3 range. No statistical difference was 
noted for gender, age, or duration of time present in regards to presence or absence of clear cells. Statistically 
significant differences in clear cell presence were found between location groups, between benign and malignant 
diagnosis, and between specific diagnostic groups. 
Conclusions: This study demonstrates the frequent presence of increased numbers of clear cells in oral salivary 
malignancies and highlights salivary gland differential diagnoses when presented with clear cell changes.
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Introduction
Clear cells may be found as incidental histologic 
findings in a multitude of benign or malignant tumors 
of many cell origins including epithelial, melanocytic, 
mesenchymal, or hematopoietic (1). They may be a 
result of many different processes, including artifact, 
degeneration of cellular organelles, or accumulation of 
substances within the cells - most commonly glycogen, 
but sometimes mucopolysaccharides, mucin, lipids, or 
foreign bodies (1,2). Within the head and neck region, 
clear cells are found most commonly in salivary gland 
tumors, but also may be seen in tumors of squamous 
or odontogenic epithelial origin, primary or metastatic 
carcinoma, benign or malignant melanocytic lesions, 
or benign or malignant mesenchymal tumors (1,3). 
Knowledge of the frequency and patterns of clear cell 
presentation in salivary gland tumors may be helpful in 
determining a diagnosis. This study serves to describe 
both the epidemiologic, clinical, and histologic features 
of a large series of salivary tumors and also to detail 
the occurrence and histologic appearance of clear cells 
found within this group of tumors. 
Material and Methods 
Institutional review board approval and permission 
for waiver of informed consent was granted from 
the University of Florida Institutional Review Board 
Ethics Committee (Approval #IRB201400598). We 
identified 641 cases of salivary tumors in the archive 
files of the University of Florida College of Dentistry’s 
Oral Pathology Laboratory (Gainesville, FL) dating 
from January 1994- January 2014. Epidemiologic data 
was collected to include age, gender, diagnosis, site of 
occurrence, and time period the lesion was present. 
In instances where both an incisional and excisional 
specimen were available, the excisional specimen was 
chosen for examination in the study. Metastatic tumors 
and cases with insufficient tissue were excluded from 
the study.  Hematoxylin and eosin stained slides were 
examined for each tumor by a panel of four Oral and 
Maxillofacial Pathologists (IB, DC, MI, SF). Clear cell 
changes were tabulated for each case with the following 
criteria: tumors with no clear cells present = grade 0 
(negative); those with few to focal clear cells (less than 
25%) = grade 1 (focal); tumors with moderate clear 
cells over 25% but less than 50%  = grade 2 (moderate); 
tumors composed of greater than 50% clear cells = 
grade 3 (diffuse). Statistical analysis was performed to 
compare differences between groups in terms of clear 
cell composition with Pearson chi-square test using IBM 
SPSS version 22, and a p-value < 0.05 was considered 
statistically significant.
Results 
The final number of cases included in the study was 
535. Examples of specimens graded as levels 0-3 may 
be seen in figure 1. An overall comparison between 
Fig. 1. Examples of Grade 0=no clear cells change (A,B), Grade 
1=focal ≤25% clear cells change (C,D), Grade 2=moderate 25% -50% 
clear cells change (E,F), Grade 3=diffuse ≥ 50%  clear cells change 
(G,H). Hematoxylin and eosin magnifi cation 5x (A,B,E,G,H) and 
20x (C,D,F).
0-1 (none to focal) clear cell score to 2-3 (moderate 
to diffuse) clear cell score in terms of demographics, 
clinical information, and diagnoses is presented in table 
1. Of the overall 535 cases analyzed, 425 (79.4%) showed 
0-1 grade clear cell change and 110 (20.6%) showed 2-3 
grade clear cell change. Gender was documented for 
all 535 cases, with a distribution of 230 males and 305 
females. Age was provided for 517/535 cases showing 
171 patients under 50 years of age and the great majority 
being age 50 and above, with 346. The slight majority 
of patients reporting duration of symptoms noted the 
lesions were present less than 1 year at time of biopsy 
(n=171/335 reported) with the remainder reporting the 
lesions present over 1 year (n=164/335 reported). There 
were no statistically significant differences in clear cell 
group levels in regards to gender, age group, or length of 
time that symptoms were reported prior to biopsy.
A comparison of clear cell level by oral cavity locations 
is summarized in figure 2. The majority of clear cell 
grade 2-3 occurred on the floor of mouth, followed in 
descending order by the retromolar pad, lower lip, palate, 
tongue, buccal mucosa, vestibule, maxillary tuberosity 
and upper lip. A statistically significant difference was 
noted between locations in terms of clear cell grade 0-1 
as compared to grade 2-3 (p=0.001). 
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Clear cell changes in regards to diagnoses are 
summarized in figure 3. For benign entities, moderate 
or diffuse clear cell change was rare, with pleomorphic 
adenoma (PA) showing the highest rate of 2-3 clear 
cell change (9%, n=16/179) followed by cystadenoma 
(including papillary cystadenoma) at 3%, or 1/30 cases. 
Both the canalicular adenoma (CA) and ductal papilloma 
groups showed no moderate or diffuse clear cell change 
in any cases. In malignant tumors, mucoepidermoid 
carcinoma (MEC) showed the highest rate of clear 
cell change with an equal 50% grade 0-1 and 50% 
2-3 clear cell change. The remaining malignant tumor 
categories were in descending order of clear cell change 
adenocarcinoma NOS demonstrating 31% (n=8/26) 
grade 2-3, and acinic cell adenocarcinoma (AcCC) had 
25% (n=3/12) grade 2-3. Adenoid cystic carcinomas 
(AdCC) had only 9% (n=3/32) with grade 2-3, followed 
by polymorphous low grade adenocarcinoma (PLGA) 
with 5% (n=1/21) grade 2-3. Other benign and malignant 
diagnoses were present only in very small numbers. 
Between diagnostic categories a statistically significant 
difference was found between 0-1 clear cell grade and 
2-3 clear cell grade (p=0.000). 
Overall clear cell changes with respect to benign and 
malignant tumors revealed that out of 284 benign 
salivary gland tumors, 93% demonstrated clear cell 
changes with a grade 0-1 while only 7% had grade 2-3 
clear cell changes. In contrast, 251 malignant tumors 
demonstrated 64% grade 0-1 clear cell changes and a 
higher number of grade 2-3 clear cells of 36%, which 
Fig. 2. Comparison of clear cell grades 0-1 to grades 2-3 by oral location.
Fig. 3. Comparison of clear cell grades 0-1 to grades 2-3 by diagnosis.
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was a statistical difference in comparison to benign 
tumors (p=0.000).
Discussion
The cases described in our series contribute one of the 
largest case series of salivary gland tumors described 
in the literature. For the most part, the demographics of 
the cases in our series are commensurate to the para-
meters previously reported. The mean age affected was 
57.7 years which is similar to overall rates mentioned 
in the literature for salivary tumors (4). Females com-
prised 57% of the patients in the study, which is also 
consistent with most cited reports (4). Due to the natu-
re of our biopsy service which is comprised mainly of 
submissions from private practice offices not involving 
a hospital setting, parotid tumor submissions were rare, 
and most cases represented minor salivary gland based 
tumors. The benign to malignant ratio in this study was 
close to equal, which is typical of minor salivary gland 
tumors (4). PA was the most common benign tumor 
in the study and MEC the most common malignancy, 
which fits with prior studies (2,5). As expected, tumors 
arising mainly in the parotid were infrequent [AcCC, 
epithelial myoepithelial carcinoma (EMC), salivary 
duct carcinoma (SDC), basal cell adenoma (BCA), basal 
cell adenocarcinoma (BCAC)] or not represented (War-
thin tumor, oncocytoma). The most common locations 
of tumors in our series were palate, followed by buccal 
mucosa, then upper lip which is consistent with repor-
ted locations for minor salivary gland lesions (4).
In considering the likelihood for clear cell change in 
salivary tumors, it is relevant to review the cellular 
origin of different types of salivary tumors. Salivary 
tumors are composed generally of either luminal or 
ductal epithelial cells, myoepithelial cells, or a mixture 
of both types (6). Monophasic epithelial cell tumors 
include AcCC (luminal acinar cells) and salivary duct 
carcinoma and canalicular adenoma (ductal cells) (6,7). 
Myoepithelioma and myoepithelial carcinoma represent 
monophasic myoepithelial tumors (6). Biphasic tumors 
with both luminal/ductal and myoepithelial elements 
include PA, EMC, and AdCC (6). The possibility of a 
role of myoepithelial cells in MEC and PLGA has been 
questioned but is controversial (8). MEC represents a 
unique tumor thought to possibly derive from pluripotent 
reserve cells of the excretory duct which may explain 
the variation in cell type noted in MEC including 
squamous, intermediate, and mucous cells (2). In the 
context of predicting clear cell change, one question 
arose of which type of salivary gland tumor cell was 
most likely to exhibit clear cell change. Myoepithelial 
cells have been observed to rarely show clear cell change 
due to glycogen accumulation (1,8,9). In addition, 
the clear cells noted in MEC have been found to be 
most similar in immunohistochemical profile to the 
intermediate cells in this tumor (2). In addition, some 
clear cell predominant salivary tumors are thought to 
be of squamous origin such as hyalinizing clear cell 
carcinoma (10). The most common tumors to show 
clear cell change in this study were tumors with either 
monophasic or biphasic myoepithelial or luminal origin 
but not typically solitary ductal origin type tumors. 
In the literature, many types of salivary tumors have 
been described to show clear cell change. Clear cells 
have been reported in benign tumors such as PA, myoe-
pithelioma, and oncocytoma, and malignant tumors 
such as myoepithelial carcinoma, oncocytic carcinoma, 
MEC, AcCC, PLGA, and AdCC (1). Clear cells are com-
monly associated with MEC, with sporadic clear cell 
change reported in up to 30% of cases, but predominant 
clear cell change is rarer (2,11). AcCC has been shown 
to feature clear cell in approximately 6% of cases, but 
with predominant clear cell populations in only 1% (1). 
In another study, light eosinophilic or clear cell change 
was noted in 35% of AcCC (12). Unlike MEC where 
clear cells result from glycogen deposition as measured 
by periodic acid-Schiff (PAS) positivity with loss after 
diastase, clear cells in AcCC do not show glycogen ac-
cumulation and are likely due to a loss of cellular orga-
nelles or proliferation of monoclonal clear acinar cells 
(1). In EMC, the ductal epithelial islands are surrounded 
commonly by myoepithelial cells exhibiting clear cell 
change (1,13). Oncocytomas may rarely show clear cell 
change relating to glycogen deposition or fixation ar-
tifact (1,13). Myoepithelial carcinoma may show clear 
cell change in approximately 16% of cases (1). Clear cell 
changes have also been reported in AdCC and PLGA, 
particularly in the solid pattern variants (14). Other sali-
vary tumors are primarily composed of clear cells such 
as hyalinizing clear cell carcinoma and clear cell carci-
noma (10). 
Our study found clear cell change to be more common 
in malignant salivary tumors compared to benign, 
which is compatible with prior reports (1). To the best 
of our knowledge, this study is the first to evaluate clear 
cell change in regards to age, gender, duration of time 
reported, or location of tumor. We found no significant 
association of clear cell change with respect to age, 
gender, or duration of time reported. The association 
noted with location are explainable primarily due to 
the predominance of tumors which may occur at those 
locations, as floor of mouth and retromolar pad had 
higher than overall clear cell change but had high rate 
of MEC in these areas (a tumor with high clear cell 
change), whereas upper lip had a lower than average 
clear cell rate but a predominance of CA in this location, 
a tumor which failed to show clear cell change. 
We were unable to measure outcome of the tumors due 
to the retrospective nature of the study and due to the 
fact that the majority of cases originated from offices 
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outside our institution it was not possible to speculate 
on clear cells as a predictor of prognosis. Prior studies 
have found no association between extensive clear 
cell change and prognosis in either MEC or AcCC (1). 
However, in other types of tumors clear cell variants have 
been associated with more aggressive behavior (15). 
The differential diagnosis for clear cell predominant 
tumors of the head and neck is broad and highly 
dependent on location. Salivary tumors may rarely occur 
intraosseously and when arising in the jawbones must 
be distinguished from odontogenic clear cell carcinoma, 
which may appear very similar to hyalinizing clear cell 
carcinoma of the salivary gland (10). Salivary lesions 
proximal to the skin due to tumor extension must be 
differentiated from a wide range of dermatologic 
lesions showing clear cell change including epidermal 
and melanocytic benign and malignant lesions (16). 
Benign melanocytic clear cell tumors including balloon 
cell nevus and cellular blue nevus along with malignant 
melanoma have been reported with predominant clear 
cell change (16). In addition, multiple benign and 
malignant adnexal eccrine and sebaceous tumors may 
show clear cell change (16). Squamous cell carcinoma 
may also show predominant clear cell populations in 
the skin in some cases (16). Myoepithelial tumors of 
soft tissue may show clear cell change in 45-55% of 
tumors but it is rarely predominant (17). Mesenchymal 
tumors with reported clear cell change include clear 
cell sarcoma, benign and malignant smooth muscle 
tumors, and perivascular epithelioid cell tumors (16). 
Finally, metastatic tumors such as renal cell carcinoma 
(RCC) are a significant consideration in evaluating 
clear cell tumors of the head and neck, but RCC is 
often distinguishable by a robust vascular network and 
distinct immunohistochemical profile (1). 
Conclusions
In conclusion, in our study population, tumors of primarily 
ductal origin rarely showed clear cell change, and malignant 
tumors were significantly more likely than benign to exhibit 
more extensive clear cell change.  Location was somewhat 
predictive of clear cell change in this study population, but 
explainable by prevalence of certain tumors in specific 
locations. Age, gender, and duration were not predictive 
of clear cell change. Clinicians and pathologists should 
carefully consider other clear cell tumors in the differential 
diagnosis when confronted with a salivary tumor with 
predominant clear cell change.
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